Insiders · Profile

BATE KENNETH

Director at MADRIGAL PHARMACEUTICALS. Filing since 1 Apr 2024. CIK 0001210238

Company
Date
Role
Action
Shares
Amount
Of holding
5 Nov 2025
Director
Sold at will
16,575
$8.03M
86.3%
15 Aug 2025
Director
Sold at will
10,000
$3.65M
79.2%
27 Feb 2025
Director
Sold at will
20,000
$7.13M
91.3%
2 Apr 2024
Director
Sold on a plan
11,212
$2.74M
90.3%
1 Apr 2024
Director
Sold on a plan
21,277
$5.47M
94.7%
5 decisions on file.